A multi-center, open-label, unilateral interaction study of UCB 34714 on stable phenytoin monotherapy during a 45 day b.i.d. administration period in 15 adult subjects suffering from epilepsy.
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2014
At a glance
- Drugs Brivaracetam; Phenytoin
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors UCB
- 31 Aug 2018 Biomarkers information updated
- 16 Jul 2007 Status changed from in progress to completed.
- 20 Feb 2007 New trial record.